Abiraterone (ABI) is a potent, selective inhibitor of androgen biosynthesis by blocking cytochrome P450 c17 (CYP17) and suppressing testosterone production by testes, adrenals and tumor cells [1,2]. Here, CYP17A1 is linked to neoplasm.